{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:31:07Z","timestamp":1788517867855,"version":"build-2803163510"},"reference-count":37,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"9","content-domain":{"domain":["ascopubs.org"],"crossmark-restriction":true},"short-container-title":["JCO Precis Oncol"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n            <jats:title>PURPOSE<\/jats:title>\n            <jats:p>Although deep targeted DNA sequencing of liquid biopsies has shown prognostic utility in large B-cell lymphoma (LBCL), the routine clinical adoption of these assays remains limited because of their high costs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MATERIALS AND METHODS<\/jats:title>\n            <jats:p>Here, leveraging a well-annotated cohort encompassing both frontline and relapsed\/refractory (R\/R) LBCL, we profiled patient plasma samples with two complementary modalities\u2014ultra-low-pass whole-genome sequencing (ULP-WGS) and deep targeted DNA sequencing, the former being a cost-effective method to profile large scale chromosomal abnormalities and estimate tumor burden.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>\n              Our findings revealed a strong association of high cell-free tumor burden by both genomic profiling modalities with established measures of tumor burden and patient survival. Notably, the associations with survival remained statistically significant after accounting for international prognostic index scoring. Furthermore, we showed that del(17p) in circulating tumor DNA as detected by ULP-WGS was strongly associated with\n              <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n              mutation status and predicted for significantly inferior outcome in frontline LBCL patients but not in patients with R\/R LBCL.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Our study demonstrates that ULP-WGS can provide robust prognostic biomarkers for both frontline and R\/R LBCL, highlighting its broad applicability for risk stratification.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1200\/po-25-00200","type":"journal-article","created":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T19:59:13Z","timestamp":1752091153000},"update-policy":"https:\/\/doi.org\/10.1200\/crossmark","source":"Crossref","is-referenced-by-count":2,"title":["Risk Assessment With Ultra-Low-Pass Whole-Genome Sequencing of Cell-Free DNA for Large B-Cell Lymphoma"],"prefix":"10.1200","clinical-trial-number":[{"clinical-trial-number":"nct03702309","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5172-6539","authenticated-orcid":true,"given":"Davidson","family":"Zhao","sequence":"first","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"},{"name":"Department of Medical Biophysics, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1243-4888","authenticated-orcid":true,"given":"No\u00e9mie","family":"Lang","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"},{"name":"H\u00f4pitaux Universitaires de Gen\u00e8ve, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8775-5507","authenticated-orcid":true,"given":"Ting","family":"Liu","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Shelton","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-0715","authenticated-orcid":true,"given":"Juan","family":"Rangel-Pati\u00f1o","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inna Y.","family":"Gong","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hong","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7662-7091","authenticated-orcid":true,"given":"Anthea","family":"Travas","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5751-3451","authenticated-orcid":true,"given":"Vanessa","family":"Murad","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Alrekhais","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3726-8994","authenticated-orcid":true,"given":"Ur","family":"Metser","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anca","family":"Prica","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1681-3837","authenticated-orcid":true,"given":"Vishal","family":"Kukreti","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sita","family":"Bhella","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5369-1501","authenticated-orcid":true,"given":"Abi","family":"Vijenthira","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Crump","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kuruvilla","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2516-8005","authenticated-orcid":true,"given":"Andrea","family":"Arruda","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Minden","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"},{"name":"Department of Medical Biophysics, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Lam","sequence":"additional","affiliation":[{"name":"Ontario Institute for Cancer Research, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0287-7124","authenticated-orcid":true,"given":"Robert","family":"Kridel","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre\u2014University Health Network, Toronto, Canada"},{"name":"Department of Medical Biophysics, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"e_1_3_9_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27075"},{"key":"e_1_3_9_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.5246"},{"key":"e_1_3_9_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012852"},{"key":"e_1_3_9_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai8545"},{"key":"e_1_3_9_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70106-3"},{"key":"e_1_3_9_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-635169"},{"key":"e_1_3_9_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00965-y"},{"key":"e_1_3_9_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-769620"},{"key":"e_1_3_9_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02775-9"},{"key":"e_1_3_9_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12126"},{"key":"e_1_3_9_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2301665"},{"key":"e_1_3_9_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00662-6"},{"key":"e_1_3_9_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01085-9"},{"key":"e_1_3_9_15_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013289"},{"key":"e_1_3_9_16_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002814"},{"key":"e_1_3_9_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-606939"},{"key":"e_1_3_9_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.797974"},{"key":"e_1_3_9_19_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015601"},{"key":"e_1_3_9_20_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.280900"},{"key":"e_1_3_9_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz474"},{"key":"e_1_3_9_22_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.107524.110"},{"key":"e_1_3_9_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty560"},{"key":"e_1_3_9_24_2","unstructured":"Li H: lh3\/seqtk: Toolkit for processing sequences in FASTA\/Q formats. https:\/\/github.com\/lh3\/seqtk"},{"key":"e_1_3_9_25_2","unstructured":"Andrew S: FastQC: A quality control tool for high throughput sequence data 2010. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/"},{"key":"e_1_3_9_26_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.213611.116"},{"key":"e_1_3_9_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp698"},{"key":"e_1_3_9_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp352"},{"key":"e_1_3_9_29_2","unstructured":"Lai D: hmmcopy_utils: Tools for extracting read counts and gc and mappability statistics in preparation for running HMMCopy. https:\/\/github.com\/shahcompbio\/hmmcopy_utils"},{"key":"e_1_3_9_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0710052104"},{"key":"e_1_3_9_31_2","unstructured":"Therneau TM: Survival analysis. https:\/\/github.com\/therneau\/survival"},{"key":"e_1_3_9_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-06-507152"},{"key":"e_1_3_9_33_2","article-title":"ZUMA-23: A global, phase 3, randomized controlled study of axicabtagene ciloleucel versus standard of care as first-line therapy in patients with high-risk large B-cell lymphoma","volume":"41","author":"Westin J","year":"2023","unstructured":"Westin J, Jacobson CA, Chavez JC, et al: ZUMA-23: A global, phase 3, randomized controlled study of axicabtagene ciloleucel versus standard of care as first-line therapy in patients with high-risk large B-cell lymphoma. J Clin Oncol 41, 2023 (suppl 16; abstr TPS7578)","journal-title":"J Clin Oncol"},{"key":"e_1_3_9_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05408-1"},{"key":"e_1_3_9_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17023"},{"key":"e_1_3_9_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-023-03676-6"},{"key":"e_1_3_9_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/his.14726"},{"key":"e_1_3_9_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2011.85"}],"container-title":["JCO Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/PO-25-00200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T19:59:20Z","timestamp":1752091160000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/PO-25-00200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1200\/PO-25-00200"],"URL":"https:\/\/doi.org\/10.1200\/po-25-00200","relation":{},"ISSN":["2473-4284"],"issn-type":[{"value":"2473-4284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"2025-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2500200"}}